BioAlliance Pharma’s clinical trials are crucial to the investigation of new therapies for improving medicines, health and life.

• Phase I
  (BA 2000/01/01) Pharmacokinetic Study, healthy volunteers (completed)
  
• Phase III
  (BA 2002/01/03) Supportive Study, Oropharyngeal Candidiasis in HIV positive patients (completed)
  
• Phase III
  (BA 2002/01/02) Pivotal Study, Oropharyngeal Candidiasis in Head and Neck cancer patients (completed)
  
• Phase III
  (BA 2004/01/04) Pivotal Study, Oropharyngeal Candidiasis in HIV positive patients (ongoing)
  

• Phase I
  (BA 2004/21/01) Pharmacokinetic Study, healthy volunteers (Completed)
  
• Phase III
  (BA 2005/21/02) Pivotal Study, Herpes Labialis (ongoing)
  

• Phase I
  (BA 1987/03/00) Refractory Solid Tumors (completed)
  
• Phase I/II
  (BA 2000/03/01) Refractory Acute Myeloid Leukemia (discontinued)
  
• Phase I/II
  (BA 2002/03/02) Liver Cancer -- Hepatocellular Carcinoma (HCC) (completed)
  
• Phase II/III
  (BA 2006/03/03) Liver Cancer--Hepatocellular Carcinoma (HCC) (ongoing))